Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1979 Jan;23(1):19–26. doi: 10.1128/iai.23.1.19-26.1979

Enhancement of resistance to murine osteogenic sarcoma in vivo by an extract of Brucella abortus (Bru-Pel): association with activation of reticuloendothelial system macrophages.

L A Glasgow, J L Crane Jr, C J Schleupner, E R Kern, J S Youngner, D S Feingold
PMCID: PMC550682  PMID: 106004

Abstract

The administration of an aqueous-ether extracted residue of Brucella abortus (Bru-Pel) inhibits development of transplanted osteogenic sarcomas in mice as evidenced by a decrease in mortality. At least one mechanism through which Bru-Pel modulates host resistance is activation of macrophages of the reticuloendothelial system. Peritoneal macrophages harvested from mice receiving Bru-Pel were cytotoxic for osteogenic sarcoma cells in vitro, limited the replication of vaccinia virus in cell cultures, and demonstrated enhanced emittance of chemiluminescence during phagocytosis of zymosan particles of Candida albicans. The concept of reticuloendothelial system activation was further supported by the evidence that administration of Bru-Pel enhanced resistance of mice to challenge with a lethal inoculum of Listeria monocytogenes. These observation support the hypothesis that Bru-Pel shares a number of characteristics with recognized immunomodulating agents and that one mechanism by which it modulates host resistance to tumors, to virus infections, and to challenge with L. monocytogenes is through activation of macrophages.

Full text

PDF
19

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Billiau A., Schonne E., Eyckmans L., De Somer P. Interferon Induction and Resistance to Virus Infection in Mice Infected with Brucella abortus. Infect Immun. 1970 Dec;2(6):698–704. doi: 10.1128/iai.2.6.698-704.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Farber P. A., Glasgow L. A. Effect of Corynebacterium acnes on interferon production in mice. Infect Immun. 1972 Sep;6(3):272–276. doi: 10.1128/iai.6.3.272-276.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Feingold D. S., Keleti G., Youngner J. S. Antiviral activity of Brucella abortus preparations; separation of active components. Infect Immun. 1976 Mar;13(3):763–767. doi: 10.1128/iai.13.3.763-767.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Fischbach J., Glasgow L. A. Effect of Corynebacterium acnes on interferon production in mouse peritoneal exudate cells. Infect Immun. 1975 Jan;11(1):80–85. doi: 10.1128/iai.11.1.80-85.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. GLASGOW L. A. LEUKOCYTES AND INTERFERON IN THE HOST RESPONSE TO VIRAL INFECTIONS. I. MOUSE LEUKOCYTES AND LEUKOCYTE-PRODUCED INTERFERON IN VACCINIA VIRUS INFECTION IN VITRO. J Exp Med. 1965 Jun 1;121:1001–1018. doi: 10.1084/jem.121.6.1001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Glasgow L. A., Crane J. L., Jr, Kern E. R. Antitumor activity of interferon against murine osteogenic sarcoma cells in vitro. J Natl Cancer Inst. 1978 Mar;60(3):659–666. doi: 10.1093/jnci/60.3.659. [DOI] [PubMed] [Google Scholar]
  7. Glasgow L. A., Fischbach J., Bryant S. M., Kern E. R. Immunomodulation of host resistance to experimental viral infections in mice: effects of Corynebacterium acnes, Corynebacterium parvum, and Bacille calmette-guérin. J Infect Dis. 1977 May;135(5):763–770. doi: 10.1093/infdis/135.5.763. [DOI] [PubMed] [Google Scholar]
  8. HIRNLE Z. The effect of Brucella abortus infection on transmissible Crocker's sarcoma in mice. Acta Med Pol. 1960;1(3-4):219–241. [PubMed] [Google Scholar]
  9. Hibbs J. B., Jr Activated macrophages as cytotoxic effector cells. Transplantation. 1975 Jan;19(1):77–81. doi: 10.1097/00007890-197501000-00015. [DOI] [PubMed] [Google Scholar]
  10. Hibbs J. B., Jr, Lambert L. H., Jr, Remington J. S. Resistance to murine tumors conferred by chronic infection with intracellular protozoa, Toxoplasma gondii and Besnoitia jellisoni. J Infect Dis. 1971 Dec;124(6):587–592. doi: 10.1093/infdis/124.6.587. [DOI] [PubMed] [Google Scholar]
  11. Hibbs J. B., Jr Role of activated macrophages in nonspecific resistance to neoplasia. J Reticuloendothel Soc. 1976 Sep;20(3):223–231. [PubMed] [Google Scholar]
  12. Kaplan A. M., Morahan P. S., Regelson W. Induction of macrophage-mediated tumor-cell cytotoxicity by pyran copolymer. J Natl Cancer Inst. 1974 Jun;52(6):1919–1923. doi: 10.1093/jnci/52.6.1919. [DOI] [PubMed] [Google Scholar]
  13. Keleti G., Feingold D. S., Youngner J. S. Antitumor activity of a Brucella abortus preparation. Infect Immun. 1977 Mar;15(3):846–849. doi: 10.1128/iai.15.3.846-849.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kern E. R., Glasgow L. A., Overall J. C., Jr Antiviral activity of an extract of Brucella abortus: induction of interferon and immunopotentiation of host resistance. Proc Soc Exp Biol Med. 1976 Jul;152(3):372–376. doi: 10.3181/00379727-152-39399. [DOI] [PubMed] [Google Scholar]
  15. Lamensans A., Chedid L., Lederer E., Rosselet J. P., Gustafson R. H., Spencer H. J., Ludwig B., Berger F. M. Enhancement of immunity against murine syngeneic tumors by a fraction extracted from non-pathogenic mycobacteria. Proc Natl Acad Sci U S A. 1975 Sep;72(9):3656–3660. doi: 10.1073/pnas.72.9.3656. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Le Garrec Y., Sabolovic D., Toujas L., Dazord L., Guelfi J., Pilet C. Activity of inactivated Burcella on murine tumors: prophylactic effects and combination with specific immunostimulation. Biomedicine. 1974 Jan 20;21(1):40–43. [PubMed] [Google Scholar]
  17. MACKANESS G. B. Cellular resistance to infection. J Exp Med. 1962 Sep 1;116:381–406. doi: 10.1084/jem.116.3.381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Morahan P. S., Glasgow L. A., Crane J. L., Jr, Kern E. R. Comparison of antiviral and antitumor activity of activated macrophages. Cell Immunol. 1977 Feb;28(2):404–415. doi: 10.1016/0008-8749(77)90122-8. [DOI] [PubMed] [Google Scholar]
  19. Morahan P. S., Kaplan A. M. Macrophage activation and anti-tumor activity of biologic and synthetic agents. Int J Cancer. 1976 Jan 15;17(1):82–89. doi: 10.1002/ijc.2910170112. [DOI] [PubMed] [Google Scholar]
  20. STINEBRING W. R., YOUNGNER J. S. PATTERNS OF INTERFERON APPEARANCE IN MICE INFECTED WITH BACTERIA OR BACTERIAL ENDOTOXIN. Nature. 1964 Nov 14;204:712–712. doi: 10.1038/204712a0. [DOI] [PubMed] [Google Scholar]
  21. Schleupner C. J., Glasgow L. A. Peritoneal macrophage activation indicated by enhanced chemiluminescence. Infect Immun. 1978 Sep;21(3):886–895. doi: 10.1128/iai.21.3.886-895.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Scott M. T. Corynebacterium parvum as an immunotherapeutic anticancer agent. Semin Oncol. 1974 Dec;1(4):367–378. [PubMed] [Google Scholar]
  23. Swartzberg J. E., Krahenbuhl J. L., Remington J. S. Dichotomy between macrophage activation and degree of protection against Listeria monocytogenes and Toxoplasma gondii in mice stimulated with Corynebacterium parvum. Infect Immun. 1975 Nov;12(5):1037–1043. doi: 10.1128/iai.12.5.1037-1043.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Veskova T. K., Chimishkyan K. L., Sver-Moldavsky G. J. Effect of Brucella abortus infection (vaccine strain 19BA) on Rauscher leukemia virus and L1210 leukemia in mice. J Natl Cancer Inst. 1974 May;52(5):1651–1653. doi: 10.1093/jnci/52.5.1651. [DOI] [PubMed] [Google Scholar]
  25. WILLIAMS C. A., Jr, DUBOS R. J. Studies on fractions of methanol extracts of tubercle bacilli. I. Fractions which increase resistance to infection. J Exp Med. 1959 Dec 1;110:981–1004. doi: 10.1084/jem.110.6.981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Youngner J. S., Keleti G., Feingold D. S. Antiviral activity of an ether-extracted nonviable preparation of Brucella abortus. Infect Immun. 1974 Dec;10(6):1202–1206. doi: 10.1128/iai.10.6.1202-1206.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES